Design and study subjects
This prospective, double-blinded, randomized dose–response clinical trial was approved by the Research Ethics Committee of Women’s Hospital, School of Medicine, Zhejiang University (Number: IRB-20210132-R). Written informed consent was obtained from all parturients. The trial was registered at the Chinese Clinical Trial Registry (ChiCTR) (